Arrowstreet Capital Limited Partnership Has $3.49 Million Position in Embecta Corp. (NASDAQ:EMBC)

Arrowstreet Capital Limited Partnership raised its holdings in shares of Embecta Corp. (NASDAQ:EMBC - Free Report) by 36.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 169,164 shares of the company's stock after acquiring an additional 44,997 shares during the period. Arrowstreet Capital Limited Partnership owned approximately 0.29% of Embecta worth $3,493,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Smartleaf Asset Management LLC grew its holdings in Embecta by 175.1% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,216 shares of the company's stock worth $25,000 after acquiring an additional 774 shares during the period. Quarry LP acquired a new position in Embecta in the 3rd quarter valued at approximately $30,000. Oppenheimer Asset Management Inc. acquired a new position in Embecta in the 4th quarter worth about $209,000. KLP Kapitalforvaltning AS acquired a new position in Embecta in the fourth quarter worth approximately $215,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in Embecta in the third quarter worth $217,000. Institutional investors own 93.83% of the company's stock.

Insider Buying and Selling

In related news, Director Milton Mayo Morris sold 3,100 shares of Embecta stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total value of $50,778.00. Following the sale, the director now owns 36,133 shares of the company's stock, valued at approximately $591,858.54. This trade represents a 7.90 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.42% of the stock is owned by insiders.

Remove Ads

Analyst Ratings Changes

Separately, Mizuho assumed coverage on shares of Embecta in a research note on Thursday. They issued a "neutral" rating and a $15.00 price objective for the company.

Embecta Stock Performance

Shares of NASDAQ EMBC traded down $0.15 during midday trading on Monday, reaching $12.16. 19,292 shares of the company traded hands, compared to its average volume of 553,903. Embecta Corp. has a 12 month low of $9.93 and a 12 month high of $21.48. The firm has a market cap of $706.62 million, a PE ratio of 12.17, a PEG ratio of 0.78 and a beta of 1.23. The stock's 50-day simple moving average is $13.73 and its 200-day simple moving average is $15.99.

Embecta (NASDAQ:EMBC - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.20. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. On average, equities research analysts expect that Embecta Corp. will post 2.85 EPS for the current year.

Embecta Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 4.94%. The ex-dividend date of this dividend was Friday, February 28th. Embecta's payout ratio is 60.00%.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.